In vivo, a murine surrogate of CUE-101 demonstrates anti-tumor activity both as a monotherapy and in combination with an anti-PD-1 antibody in the TC-1 E6/E7+ tumor model. The gene discussed is PDCD1; the disease is neoplasm.